Anti-Obesity Prescription Market

Anti-Obesity Prescription Market: Global Industry Analysis and Forecast to 2020

Anti-Obesity Prescription Market Segmented By conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma

Market Overview

Globally, obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues.

Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense.

North America dominates the global market for anti-obesity prescription due to increasing prevalence of obesity and lifestyle associated diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in the global anti-obesity prescription market.

China and India are expected to be the fastest growing anti-obesity prescription markets in Asia-Pacific region. Some of the key driving forces for anti-obesity prescription market in emerging countries are large pool of patients, increased government funding and improving healthcare infrastructure.

In recent times there is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market.

In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market.

New researches for discovery of novel drugs for treatment of obesity would develop opportunity for the global anti-obesity prescription market. However, unfavorable reimbursements policies could lead a challenge for the global anti-obesity prescription market.

Some of the major companies operating in the global anti-obesity prescription market are 7TM Pharma, Zydus Cadila, Akrimax Pharmaceuticals, Zealand Pharma, Arrowhead Research, Arena Pharmaceuticals, Inc., Compellis Pharmaceuticals, Yungjin Pharm, Alpex Pharma SA and Bridge BioResearch.

Find Out More about the Report Coverage

Key points covered in the report

  • Report segments the market on the basis of types, application, products, technology, etc (as applicable)
  • The report covers geographic segmentation

    • North America
    • Europe
    • Asia
    • RoW
  • The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
  • The report provides company profiles of some of the leading companies operating in the market
  • The report also provides porters five forces analysis of the market.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Recommendations

Perineal Care Market

Perineal Care Market is expected to register a CAGR of 4.6% from 2017 to 2025. In 2017, the marker was worth US$ 878.2 Mn and it is expected to reach a valuation of US$ 1,254.8 Mn by the end of 2025..

Infection Surveillance Solutions Market

Global infection surveillance solution market to increase from more than US$ 300 Mn in 2017 to about US$ 905 Mn by 2025 end, representing a CAGR of 14.04% from 2017-2025.

Norovirus Diagnostics Market

Global norovirus diagnostics market was valued at US$ 47.6 Mn in 2020, and is expected to exhibit a CAGR of around 8.4% over the forecast period (2021-2031)..

Hospital Acquired Infection Control Market

The hospital acquired infection control market in 2020 was worth US$ 5.5 Bn, which is expected to expand 1.6X by the end of the decade..

Our Clients

Our Clients